Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RBC Capital Markets
Biotech
Sarepta rewarded by Wall Street for FDA committee shocker
Sarepta's shares skyrocketed Monday after FDA advisers endorsed the risk-benefit profile of the company's DMD gene therapy.
Max Bayer
May 15, 2023 11:05am
Biotech leaders call on industry to cut ties with Russia
Feb 24, 2022 4:00pm
BioMarin's hemophilia A gene therapy hits goal in phase 3
Jan 10, 2022 8:10am
Enanta dumps oral hep B program after safety warnings
Nov 19, 2021 8:35am
FDA said no in July, so Iterum will test UTI antibiotic again
Sep 29, 2021 10:05am
